Oncology & Cancer

Moderna CEO says melanoma vaccine could be available by 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

Medications

Clinical trial investigates new oral treatment for COVID-19

An exploratory clinical trial (SIGMA4COVID) through a collaboration between Catalonia and Galicia, the results of which are published in the Journal of Infection, suggests the usefulness of a drug, E-52862, for the treatment ...

Diseases, Conditions, Syndromes

Vaping can increase susceptibility to infection by SARS-CoV-2

Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a study by a research team at University of California, Riverside, has found.

page 9 from 40